Thermo Fisher (TMO) Agrees to Acquire Brahms for $470M
Thermo Fisher Scientific Inc (NYSE: TMO) has agreed to acquire German disease diagnostics firm Brahms, for $470M. Thermo Fisher expects the deal to add to its earnings per share in 2010. Brahms, which makes diagnostic tests used by laboratories, generated revenue of about $105 million in 2008.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.